AMANDA BOONE: Open Payments
NPI 1962922997 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 29 payments from 11 companies in 2025. Trend: 2023 $747 · 2024 $1,271 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $204 |
| ABBVIE INC. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Abbott Laboratories | 3 | $48 |
| PFIZER INC. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Cosette Pharmaceuticals Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Indivior Inc. | 1 | $14 |
Products named: Wegovy, AIRSUPRA, FREESTYLE LIBRE 3, Ozempic, QULIPTA, MAVYRET, NURTEC ODT, LEQVIO.
Industry payments across DE — which companies pay providers there.
